221 related articles for article (PubMed ID: 519952)
1. Distribution of circulating immunoreactive components of parathyroid hormone in normal subjects and in patients with primary and secondary hyperparathyroidism: the role of the kidney and of the serum calcium concentration.
Dambacher MA; Fischer JA; Hunziker WH; Born W; Moran J; Roth HR; Delvin EE; Glorieux FH
Clin Sci (Lond); 1979 Nov; 57(5):435-43. PubMed ID: 519952
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of a radioimmunoassay for parathyroid hormone in human serum.
Almqvist S; Hjern B; Wästhed B
Acta Endocrinol (Copenh); 1975 Mar; 78(3):493-509. PubMed ID: 1173015
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Regulation of circulating parathyroid hormone levels: normal physiology and consequences in disorders of mineral metabolism.
Fischer JA; Blum JW; Hunziker W; Binswanger U
Klin Wochenschr; 1975 Oct; 53(20):939-54. PubMed ID: 1202277
[TBL] [Abstract][Full Text] [Related]
6. Renal adenylate cyclase assay for biologically active parathyroid hormone: clinical utility and physiological significance.
Auf'mkolk B; Hesch RD
J Endocrinol; 1986 Jan; 108(1):9-15. PubMed ID: 3944539
[TBL] [Abstract][Full Text] [Related]
7. Circulating molecular forms of parathyroid hormone in primary and secondary hyperparathyroidism.
Brandão CM; Kasamatsu TS; Oliveira MA; Vieira JG
Braz J Med Biol Res; 1989; 22(8):963-5. PubMed ID: 2633848
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure.
Gautvik KM; Gautvik VT; Halvorsen JF
Scand J Clin Lab Invest; 1983 Nov; 43(7):553-64. PubMed ID: 6658372
[TBL] [Abstract][Full Text] [Related]
9. An adenylate cyclase bioassay for parathyroid hormone: some clinical experiences.
Seshadri MS; Chan YL; Wilkinson MR; Mason RS; Posen S
Clin Sci (Lond); 1985 Mar; 68(3):321-6. PubMed ID: 3971662
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of a diurnal variation in serum parathyroid hormone in primary and secondary hyperparathyroidism.
Sinha TK; Miller S; Feming J; Khairi R; Edmondson J; Johnston CC; Bell NH
J Clin Endocrinol Metab; 1975 Dec; 41(06):1009-13. PubMed ID: 1239461
[TBL] [Abstract][Full Text] [Related]
11. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients.
Boudville NC; Hodsman AB
Nephrol Dial Transplant; 2006 Sep; 21(9):2621-4. PubMed ID: 16644777
[TBL] [Abstract][Full Text] [Related]
12. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
Kruse K; Kracht U; Wohlfart K; Kruse U
Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
[TBL] [Abstract][Full Text] [Related]
13. Development and application of a mid-region specific assay for human parathyroid hormone.
Gleed JH; Hendy GN; Nussbaum SR; Rosenblatt M; O'Riordan JL
Clin Endocrinol (Oxf); 1986 Apr; 24(4):365-73. PubMed ID: 3742832
[TBL] [Abstract][Full Text] [Related]
14. Peripheral metabolism of parathyroid hormone in patients with primary hyperparathyroidism as judged by immunological and biological studies.
Gautvik KM; Gordeladze JO; Moxheim E; Gautvik VT
Eur Surg Res; 1984; 16 Suppl 2():41-54. PubMed ID: 6723731
[TBL] [Abstract][Full Text] [Related]
15. Dissociation of parathyroid hormone bioactivity and immunoreactivity in pseudohypoparathyroidism type I.
de Deuxchaisnes CN; Fischer JA; Dambacher MA; Devogelaer JP; Arber CE; Zanelli JM; Parsons JA; Loveridge N; Bitensky L; Chayen J
J Clin Endocrinol Metab; 1981 Dec; 53(6):1105-9. PubMed ID: 7298795
[TBL] [Abstract][Full Text] [Related]
16. Comparison of C-terminal and N-terminal PTH in secondary hyperparathyroidism in renal failure.
Hortling L; Puutula-Räsänen L; Fyhrquist F
Scand J Urol Nephrol Suppl; 1985; 90():51-4. PubMed ID: 3868028
[TBL] [Abstract][Full Text] [Related]
17. Biochemical spectrum of parathyroid disorders diagnosed at a tertiary care setting.
Khan NB; Nawaz MA; Ijaz A; Memon AA; Asif N; Khadim MT; Sawal HA
J Pak Med Assoc; 2020 Feb; 70(2):243-247. PubMed ID: 32063614
[TBL] [Abstract][Full Text] [Related]
18. [Calcium metabolism abnormalities and the levels of parathyroid hormone and calcitonin in the blood].
Fujita T
Nihon Rinsho; 1972 Mar; 30(3):744-50. PubMed ID: 4558434
[No Abstract] [Full Text] [Related]
19. Heterogeneity of carboxyl-terminal parathyroid hormone circulating forms in patients with hyperparathyroidism due to end stage renal disease.
Vieira JG; Kunii IS; Ohe MN; Carvalho AB
Arq Bras Endocrinol Metabol; 2009 Dec; 53(9):1074-8. PubMed ID: 20126864
[TBL] [Abstract][Full Text] [Related]
20. Conventional and new diagnostic applications of a two-site immunochemiluminometric assay for parathyroid hormone.
Minisola S; Scarnecchia L; Romagnoli E; Carnevale V; Pacitti MT; Scarda A; Rosso R; Mazzuoli GF
J Endocrinol Invest; 1992; 15(7):483-9. PubMed ID: 1447486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
